JP2022177119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022177119A5 JP2022177119A5 JP2022144243A JP2022144243A JP2022177119A5 JP 2022177119 A5 JP2022177119 A5 JP 2022177119A5 JP 2022144243 A JP2022144243 A JP 2022144243A JP 2022144243 A JP2022144243 A JP 2022144243A JP 2022177119 A5 JP2022177119 A5 JP 2022177119A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- administration
- drug
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025044178A JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944674P | 2019-12-06 | 2019-12-06 | |
| US62/944,674 | 2019-12-06 | ||
| US202063077996P | 2020-09-14 | 2020-09-14 | |
| US63/077,996 | 2020-09-14 | ||
| US202063109698P | 2020-11-04 | 2020-11-04 | |
| US63/109,698 | 2020-11-04 | ||
| JP2021557408A JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
| PCT/US2020/063089 WO2021113497A1 (en) | 2019-12-06 | 2020-12-03 | Dosing of a bruton's tyrosine kinase inhibitor |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Division JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044178A Division JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022177119A JP2022177119A (ja) | 2022-11-30 |
| JP2022177119A5 true JP2022177119A5 (enExample) | 2023-10-31 |
| JP7654604B2 JP7654604B2 (ja) | 2025-04-01 |
Family
ID=73854977
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Active JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
| JP2022144243A Active JP7654604B2 (ja) | 2019-12-06 | 2022-09-12 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
| JP2025044178A Pending JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Active JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044178A Pending JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12551463B2 (enExample) |
| EP (1) | EP4069219A1 (enExample) |
| JP (3) | JP7142173B2 (enExample) |
| KR (2) | KR20230127372A (enExample) |
| CN (1) | CN115175677A (enExample) |
| AU (2) | AU2020397034B2 (enExample) |
| BR (1) | BR112022009716A2 (enExample) |
| IL (1) | IL292882A (enExample) |
| MX (1) | MX2022006631A (enExample) |
| WO (1) | WO2021113497A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7286755B2 (ja) | 2018-07-31 | 2023-06-05 | ロクソ オンコロジー， インコーポレイテッド | （ｓ）－５－アミノ－３－（４－（（５－フルオロ－２－メトキシベンズアミド）メチル）フェニル）－１－（１，１，１－トリフルオロプロパン－２－イル）－１ｈ－ピラゾール－４－カルボキサミドの噴霧乾燥分散体および製剤 |
| MX2022006631A (es) * | 2019-12-06 | 2022-09-07 | Loxo Oncology Inc | Dosificacion de un inhibidor de la tirosina cinasa de bruton. |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA018573B1 (ru) | 2006-09-22 | 2013-09-30 | Фармасайкликс, Инк. | Ингибиторы тирозинкиназы брутона |
| BR112015009624A2 (pt) | 2012-11-02 | 2017-11-14 | Pfizer | inibidores de tirosina cinase de bruton |
| US9717745B2 (en) | 2015-03-19 | 2017-08-01 | Zhejiang DTRM Biopharma Co. Ltd. | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases |
| UA127863C2 (uk) * | 2015-12-16 | 2024-01-31 | Локсо Онколоджі, Інк. | Сполуки, які можна застосовувати як інгібітори кінази |
| WO2017132474A1 (en) | 2016-01-30 | 2017-08-03 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| CN110483501B (zh) | 2016-08-05 | 2022-07-01 | 密歇根大学董事会 | 作为bcl-2抑制剂的n-(苯基磺酰基)苯甲酰胺及相关化合物 |
| EP3565815B1 (en) | 2017-01-07 | 2024-03-13 | Fochon Pharmaceuticals, Ltd. | Compounds as bcl-2-selective apoptosis-inducing agents |
| HUE060310T2 (hu) | 2017-04-18 | 2023-02-28 | Shanghai Fochon Pharmaceutical Co Ltd | Apoptosis-indukáló szerek |
| CN110869391A (zh) | 2017-07-26 | 2020-03-06 | 豪夫迈·罗氏有限公司 | 用BET抑制剂,Bcl-2抑制剂和抗CD20抗体的组合疗法 |
| CA3087262A1 (en) | 2018-01-10 | 2019-07-18 | Recurium Ip Holdings, Llc | Benzamide compounds |
| MX2020011495A (es) | 2018-04-29 | 2021-01-15 | Beigene Ltd | Inhibidores de bcl-2. |
| JP7286755B2 (ja) | 2018-07-31 | 2023-06-05 | ロクソ オンコロジー， インコーポレイテッド | （ｓ）－５－アミノ－３－（４－（（５－フルオロ－２－メトキシベンズアミド）メチル）フェニル）－１－（１，１，１－トリフルオロプロパン－２－イル）－１ｈ－ピラゾール－４－カルボキサミドの噴霧乾燥分散体および製剤 |
| MX2022006631A (es) * | 2019-12-06 | 2022-09-07 | Loxo Oncology Inc | Dosificacion de un inhibidor de la tirosina cinasa de bruton. |
-
2020
- 2020-12-03 MX MX2022006631A patent/MX2022006631A/es unknown
- 2020-12-03 KR KR1020237028538A patent/KR20230127372A/ko active Pending
- 2020-12-03 JP JP2021557408A patent/JP7142173B2/ja active Active
- 2020-12-03 US US17/782,758 patent/US12551463B2/en active Active
- 2020-12-03 KR KR1020227022407A patent/KR20220100992A/ko not_active Ceased
- 2020-12-03 EP EP20825385.6A patent/EP4069219A1/en active Pending
- 2020-12-03 AU AU2020397034A patent/AU2020397034B2/en active Active
- 2020-12-03 IL IL292882A patent/IL292882A/en unknown
- 2020-12-03 BR BR112022009716A patent/BR112022009716A2/pt unknown
- 2020-12-03 WO PCT/US2020/063089 patent/WO2021113497A1/en not_active Ceased
- 2020-12-03 CN CN202080095816.0A patent/CN115175677A/zh active Pending
-
2022
- 2022-09-12 JP JP2022144243A patent/JP7654604B2/ja active Active
-
2024
- 2024-02-26 AU AU2024201263A patent/AU2024201263B2/en active Active
-
2025
- 2025-03-19 JP JP2025044178A patent/JP2025098099A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022180461A5 (enExample) | ||
| JP6117845B2 (ja) | ニタゾキサニドの制御放出医薬配合物 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2010522135A (ja) | 医薬組成物 | |
| JP2018507243A5 (enExample) | ||
| JP2021504384A5 (enExample) | ||
| JP2022177119A5 (enExample) | ||
| JP2021509395A5 (enExample) | ||
| RU2010109359A (ru) | Азитромицин для лечения кожных заболеваний | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2016505050A5 (enExample) | ||
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2004091473A (ja) | 色素沈着改善治療薬 | |
| BR112019026029A2 (pt) | Formulações farmacêuticas orais de remogliflozina | |
| JP2021503448A5 (enExample) | ||
| IL292882A (en) | Dosage of Bruton's tyrosine kinase inhibitor | |
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| JP6454436B1 (ja) | ペマフィブラートを含有する医薬 | |
| CN113557016A (zh) | 衣壳组装调节剂固体配制品 | |
| US20210283096A1 (en) | Methods of treating obesity in responder and non-responder populations | |
| RU2003100081A (ru) | Способы и композиции, в которых используется сулодексид, для лечения диабетической нефропатии | |
| JPWO2023049920A5 (enExample) | ||
| US12168000B2 (en) | Methods of treating pain | |
| CN1537006A (zh) | 含有米尔塔扎平和对乙酰氨基酚或一种非甾类消炎药的用于治疗头痛的联合用药物 | |
| US20190381034A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases |